News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
805,608 Results
Type
Article (72585)
Company Profile (671)
Press Release (732352)
Section
Business (226335)
Career Advice (3624)
Deals (38034)
Drug Delivery (127)
Drug Development (88707)
Employer Resources (183)
FDA (17648)
Job Trends (16921)
News (383327)
Policy (37373)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (14)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (15)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2964)
Academic (1)
Accelerated approval (3)
Adcomms (22)
Allergies (87)
Alliances (55262)
ALS (91)
Alzheimer's disease (1462)
Antibody-drug conjugate (ADC) (136)
Approvals (17624)
Artificial intelligence (279)
Autoimmune disease (20)
Automation (14)
Bankruptcy (363)
Best Places to Work (12608)
BIOSECURE Act (21)
Biosimilars (113)
Biotechnology (462)
Bladder cancer (62)
Brain cancer (28)
Breast cancer (266)
Cancer (2110)
Cardiovascular disease (172)
Career advice (3065)
Career pathing (33)
CAR-T (159)
Cell therapy (447)
Cervical cancer (19)
Clinical research (71407)
Collaboration (825)
Compensation (457)
Complete response letters (29)
COVID-19 (2828)
CRISPR (42)
C-suite (221)
Cystic fibrosis (105)
Data (1948)
Decentralized trials (2)
Denatured (33)
Depression (49)
Diabetes (264)
Diagnostics (6857)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (133)
Drug pricing (120)
Drug shortages (32)
Duchenne muscular dystrophy (89)
Earnings (93423)
Editorial (39)
Employer branding (25)
Employer resources (159)
Events (127638)
Executive appointments (668)
FDA (18798)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (740)
Gene editing (107)
Generative AI (30)
Gene therapy (313)
GLP-1 (808)
Government (5032)
Grass and pollen (4)
Guidances (48)
Healthcare (20827)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (121)
Indications (27)
Infectious disease (2974)
Inflammatory bowel disease (146)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (87)
Interviews (701)
IPO (17302)
IRA (51)
Job creations (4819)
Job search strategy (2520)
Kidney cancer (10)
Labor market (31)
Layoffs (520)
Leadership (20)
Legal (9212)
Liver cancer (75)
Lung cancer (309)
Lymphoma (134)
Machine learning (2)
Management (64)
Manufacturing (303)
MASH (65)
Medical device (14487)
Medtech (14491)
Mergers & acquisitions (21229)
Metabolic disorders (708)
Multiple sclerosis (74)
NASH (23)
Neurodegenerative disease (97)
Neuropsychiatric disorders (31)
Neuroscience (1982)
NextGen: Class of 2025 (7582)
Non-profit (5070)
Northern California (2446)
Now hiring (37)
Obesity (386)
Opinion (267)
Ovarian cancer (74)
Pain (87)
Pancreatic cancer (79)
Parkinson's disease (140)
Partnered (21)
Patents (213)
Patient recruitment (97)
Peanut (51)
People (63626)
Pharmaceutical (139)
Pharmacy benefit managers (21)
Phase I (22184)
Phase II (31129)
Phase III (23449)
Pipeline (1003)
Podcasts (106)
Policy (132)
Postmarket research (3126)
Preclinical (9697)
Press Release (72)
Prostate cancer (96)
Psychedelics (36)
Radiopharmaceuticals (266)
Rare diseases (392)
Real estate (7096)
Recruiting (75)
Regulatory (25237)
Reports (40)
Research institute (2639)
Resumes & cover letters (574)
Rett syndrome (3)
RNA editing (2)
RSV (44)
Schizophrenia (73)
Series A (130)
Series B (83)
Service/supplier (26)
Sickle cell disease (54)
Southern California (2131)
Special edition (18)
Spinal muscular atrophy (162)
Sponsored (33)
Startups (4016)
State (2)
Stomach cancer (15)
Supply chain (65)
The Weekly (70)
United States (22294)
Vaccines (754)
Venture capitalists (39)
Webinars (12)
Weight loss (284)
Women's health (35)
Worklife (18)
Date
Last 7 days (592)
Last 30 days (2574)
Last 365 days (36313)
2025 (8388)
2024 (37977)
2023 (42499)
2022 (53845)
2021 (58634)
2020 (57600)
2019 (51201)
2018 (38929)
2017 (36004)
2016 (36734)
2015 (43408)
2014 (38158)
2013 (34687)
2012 (35434)
2011 (35625)
2010 (35612)
Location
Africa (1125)
Alabama (55)
Alaska (7)
Arizona (250)
Arkansas (14)
Asia (47149)
Australia (8288)
California (5703)
Canada (1893)
China (498)
Colorado (259)
Connecticut (283)
Delaware (133)
Europe (107261)
Florida (834)
Georgia (203)
Hawaii (1)
Idaho (63)
Illinois (569)
India (27)
Indiana (312)
Iowa (9)
Japan (141)
Kansas (107)
Kentucky (27)
Louisiana (11)
Maine (68)
Maryland (895)
Massachusetts (4424)
Michigan (232)
Minnesota (394)
Mississippi (2)
Missouri (85)
Montana (31)
Nebraska (26)
Nevada (58)
New Hampshire (68)
New Jersey (1631)
New Mexico (31)
New York (1628)
North Carolina (1061)
North Dakota (8)
Northern California (2446)
Ohio (204)
Oklahoma (15)
Oregon (47)
Pennsylvania (1273)
Puerto Rico (10)
Rhode Island (29)
South America (1511)
South Carolina (19)
South Dakota (1)
Southern California (2131)
Tennessee (95)
Texas (862)
Utah (173)
Virginia (150)
Washington D.C. (63)
Washington State (554)
West Virginia (3)
Wisconsin (61)
805,608 Results for "new york state coalition opposed to fluoridation nyscof".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test
March 27, 2025
·
5 min read
Press Releases
SOLVD Health Receives New York State Laboratory Approval
December 24, 2024
·
2 min read
GLP-1s
Coalition Urges FDA to Act as Report Finds Illegal GLP-1 Ingredients ‘Flooding’ Into US
Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, according to a new analysis. Separately, a group of state attorneys general has raised concerns about the unsafe GLP-1 drugs finding their way to American consumers.
February 21, 2025
·
4 min read
·
Tristan Manalac
Press Releases
Castle Biosciences Announces New York State Department of Health Approval of Its TissueCypher® Barrett’s Esophagus Test
January 6, 2025
·
5 min read
Job Trends
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
November 21, 2024
·
1 min read
·
Chantal Dresner
Pharm Country
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health (“NYSDOH”) approved the Company’s TR8™ PGx (“TR8") pharmacogenomic (PGx) testing service.
June 13, 2024
·
5 min read
Press Releases
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
November 6, 2024
·
5 min read
Press Releases
NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
October 23, 2024
·
5 min read
Press Releases
Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025
February 11, 2025
·
4 min read
Policy
New York State Laboratory Approved for Genetic Testing Using Saliva
Quadrant Laboratories announced that its Syracuse-based lab has been approved by the New York State Department of Health for genetic testing.
October 17, 2023
·
2 min read
1 of 80,561
Next
